15.286 articles found

The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.

Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM.

Toxicology · 2013-01-04

DOI: 10.1016/j.tox.2012.12.016PMID: 23295711

Pharmacological and genetic modifications in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease

Mounsey RB.

· 2013-01-01

Synucleins in the midbrain dopaminergic system : the role in health and disease

Connor-Robson N.

· 2013-01-01

The role of genetic variations on gene expression and splicing in control human brain : dissection of the aetiology of complex neurological diseases

Trabzuni D.

· 2013-01-01

A proof of concept study of epigenetics as a marker of neuropsychiatric symptoms in Parkinson's disease

Moore K.

· 2013-01-01

Molecular and behavioural characterisation of novel α-synuclein BAC transgenic mouse models of Parkinson's disease

Janezic S.

· 2013-01-01

Linking the structure of alpha-synuclein oligmers to function in Parkinson's disease

Illes-Toth TE.

· 2013-01-01

Modelling Parkinson's disease with α-synuclein transgenic mice

Scudamore O.

· 2013-01-01

Epigenetics in Parkinson's and Alzheimer's diseases.

Marques S, Outeiro TF.

Subcell Biochem · 2013-01-01

DOI: 10.1007/978-94-007-4525-4_22PMID: 23150265

A genetic dissection of antipsychotic induced movement disorders.

Crisafulli C, Drago A, Sidoti A, Serretti A.

Curr Med Chem · 2013-01-01

DOI: 10.2174/092986713804870882PMID: 23157623

Genetically modified mice as a strategy to unravel the role played by the Na(+)/Ca (2+) exchanger in brain ischemia and in spatial learning and memory deficits.

Molinaro P, Cataldi M, Cuomo O, Viggiano D, Pignataro G, Sirabella R, Secondo A, Boscia F, Pannaccione A, Scorziello A, Sokolow S, Herchuelz A, Di Renzo G, Annunziato L.

Adv Exp Med Biol · 2013-01-01

DOI: 10.1007/978-1-4614-4756-6_18PMID: 23224882

The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Lashuel HA, Overk CR, Oueslati A, Masliah E.

Nat Rev Neurosci · 2013-01-01

DOI: 10.1038/nrn3406PMID: 23254192